A 12-Week Randomized, Double-Blind, Multicenter Pilot Study to Evaluate the Effect of Etanercept 100 mg and 50 mg Weekly in Subjects With Ankylosing Spondylitis.

Trial Profile

A 12-Week Randomized, Double-Blind, Multicenter Pilot Study to Evaluate the Effect of Etanercept 100 mg and 50 mg Weekly in Subjects With Ankylosing Spondylitis.

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Jun 2011

At a glance

  • Drugs Etanercept (Primary)
  • Indications Ankylosing spondylitis
  • Focus Therapeutic Use
  • Acronyms LOADET
  • Sponsors Wyeth
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 16 Jun 2010 Results presented at 11th Annual Congress of the European League Against Rheumatism (EULAR) 2010
    • 14 Aug 2009 Actual end date changed from Feb 2008 to Jun 2008 and actual number of patients (108) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top